Pulmosil Injection 12.5 ml
₹2,195.00
Attributes
- Is Prescription Required
- Yes
- Is Returnable
- No
- Type
- Pharma
- Consume Type
- Parenteral
- Pack Size
- 12.5
- Cold Chain Product
- Yes
- Banned
- No
- Marketer Address
- Sun Pharmaceutical Industries Ltd., SUN HOUSE, CTS No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063
- Pack Form
- Vial
- Product Form
- Injection
- Unit Of Measurement
- ml
- Subcategory
- Urinary Tract Infection
- Manufacturer
- Sun Pharmaceutical Industries Ltd
- Country Of Origin
- India
- Classifier 1
- GENITO URINARY
- Classifier 2
- MALE REPRODUCTIVE SYSTEM
- Classifier 3
- BPH AND ERECTILE DYSFUNCTION
- Restricted
- Yes
- Is Sensitive
- Yes
- Dosage Forms
- Injection
- Unitprice
- ₹154.53 / 1 ml
- Dpco Drug
- No
Description
Key Benefits
Pulmosil Injection 12.5 ml belongs to the group of medicines called phosphodiesterase type-5 (PDE-5) inhibitors used to treat pulmonary arterial hypertension (high blood pressure in the lungs) to improve the ability to exercise and to slow down clinical worsening. Pulmosil Injection 12.5 ml relaxes the blood vessels, increases the blood supply to the lungs and reduces the workload of the heart. Thereby, treats pulmonary arterial hypertension.
Directions for Use
Pulmosil Injection 12.5 ml will be administered by a healthcare professional. Do not self-administer.
Side Effects
- Headache
- Indigestion
- Flushing
- Insomnia (sleep disorder)
- Diarrhoea
Storage
Store in a cool and dry place away from sunlight
Additional information
| Is Prescription Required | |
|---|---|
| Is Returnable | |
| Type | |
| Consume Type | |
| Pack Size | |
| Cold Chain Product | |
| Banned | |
| Marketer Address | |
| Pack Form | |
| Product Form | |
| Unit Of Measurement | |
| Subcategory | |
| Manufacturer | |
| Country Of Origin | |
| Classifier 1 | |
| Classifier 2 | |
| Classifier 3 | |
| Restricted | |
| Is Sensitive | |
| Dosage Forms | |
| Unitprice | |
| Dpco Drug |
